Results 251 to 260 of about 118,814 (348)

Mapping Intracellular Volume Fraction With Susceptibility Source Decomposition as a Marker for Tissue Cellularity

open access: yesJournal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Pathophysiological changes affect tissue cell composition and density. For example, neurodegenerative disorders and brain tumors are associated with cell loss and abnormal accumulation, respectively. In these scenarios, if monitored and tracked, tissue cellularity might be used to inform clinical diagnosis and management. Purpose To
Giulia Debiasi   +7 more
wiley   +1 more source

Myelin oligodendrocyte glycoprotein antibody-associated disease mimicking CLIPPERS syndrome: case report and literature review

open access: gold
Julio César Mantilla - Pardo   +3 more
openalex   +1 more source

Movement Disorders in Neuromyelitis Optica Spectrum Disorder: A Systematic Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Several movement disorders (MD) have been reported to occur in neuromyelitis optica spectrum disorder (NMOSD). No extensive review has addressed the whole spectrum of MD in NMOSD. Objective This article aims to review MD in NMOSD, describing its prevalence and features.
Luciana A.F. Bringel   +18 more
wiley   +1 more source

Ezh2 Loss-of-Function Alters Zebrafish Cerebellum Development. [PDF]

open access: yesInt J Mol Sci
Hanot M   +4 more
europepmc   +1 more source

The m<sup>6</sup>A Modification in Neurodegenerative Disease: A Cellular Perspective. [PDF]

open access: yesCells
Wang S   +9 more
europepmc   +1 more source

Tumor Organoids: Breakthroughs in Clinical Decision Making, Drug Development, and Translational Advances Beyond Conventional Models

open access: yesMed Research, EarlyView.
ABSTRACT Tumor organoid models are revolutionizing cancer research by bridging the translational gap between conventional two‐dimensional cell cultures and animal models. This Editorial thoroughly explores the fundamental innovations of patient‐derived organoid technology.
Yimao Wu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy